{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:27:14Z","timestamp":1767144434917,"version":"build-2238731810"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bcmd.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T14:10:46Z","timestamp":1462716646000},"page":"28-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["High abundance of circulating megakaryocytic cells in chronic myeloid leukemia in Indian patients. Revisiting George Minot to re-interpret megakaryocytic maturation"],"prefix":"10.1016","volume":"60","author":[{"given":"Mona","family":"Anand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswadip","family":"Hazarika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajive","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2016.05.003_bb0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00000441-196609000-00009","article-title":"The megakaryocyte blood count","volume":"252","author":"Melamed","year":"1966","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0609.1977.tb01474.x","article-title":"The peripheral blood in chronic granulocytic leukemia: study of 50 untreated Philadelphia-positive cases","volume":"18","author":"Spiers","year":"1977","journal-title":"Scand. J. Haematol."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0015","series-title":"Bone Marrow Pathology","author":"Bain","year":"1992"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0020","series-title":"Blood Cells: A Practical Guide","author":"Bain","year":"1995"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0025","series-title":"Blood Textbook of Hematology","author":"Jandl","year":"1996"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0030","series-title":"Neoplastic Disease of the Blood","first-page":"21","article-title":"Pathology and morphology of chronic leukemia and related disorders","author":"Stone","year":"1995"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0035","series-title":"Leukemia Diagnosis","author":"Bain","year":"1999"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0040","series-title":"Wintrobe's Clinical Hematology","first-page":"2342","article-title":"Chronic myeloid leukemia","author":"Larson","year":"1999"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2141.1981.tb02765.x","article-title":"Staging of chronic myeloid leukemia","volume":"47","author":"Tura","year":"1981","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0055","series-title":"Laboratory Hematology","first-page":"289","article-title":"Chronic myelogenous leukemia","volume":"1","author":"Brunning","year":"1984"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0060","series-title":"In Symmers Systemic Pathology Blood and Bone Marrow","first-page":"204","article-title":"Disorders affecting leukocytes","volume":"2","author":"Bain","year":"1986"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0065","series-title":"Hematology","first-page":"202","article-title":"Chronic myelogenous leukemia and related disorders","author":"Lichtman","year":"1990"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0070","series-title":"Tumors of the Bone Marrow","author":"Bruning","year":"1993"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0075","series-title":"Clinical and Laboratory Practice","first-page":"1225","article-title":"Laboratory evaluation of chronic myelogenous leukemia","author":"Le Beau","year":"1993"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0080","series-title":"Oxford Textbook of Oncology. Peckham M","first-page":"1648","article-title":"The chronic leukemias","author":"Singer","year":"1995"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0085","series-title":"Blood: Principles and Practice of Hematology","first-page":"457","article-title":"Chronic myelogenous leukemia","author":"Goldman","year":"1995"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0090","series-title":"Leukemia","first-page":"535","article-title":"Chronic myeloid leukemia","author":"Barnett","year":"1996"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0095","series-title":"Cancer Medicine","first-page":"2651","article-title":"Chronic myeloid leukemia","author":"Silver","year":"1997"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2141.1997.d01-1982.x","article-title":"Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period","volume":"96","author":"Savage","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0105","series-title":"Postgraduate Hematology","first-page":"434","article-title":"Chronic myeloid leukemia","author":"Goldman","year":"1999"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0110","series-title":"Textbook of Malignant Hematology","first-page":"815","article-title":"Chronic myeloid leukemia","author":"Guilhot","year":"1999"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0115","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","article-title":"A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group","volume":"90","author":"Hasford","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0120","series-title":"Clinical Oncology","author":"Abeloff","year":"2000"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0125","series-title":"Neoplastic Hematopathology","first-page":"1745","article-title":"Chronic myeloid leukemia and the chronic myeloproliferative diseases","author":"Anastasi","year":"2000"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0130","series-title":"Handbook of Hematologic Pathology","article-title":"Chronic leukemias","author":"Graham","year":"2000"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0135","series-title":"Cancer, Principles and Practice of Oncology","first-page":"2433","article-title":"Chronic myeloid leukemia","author":"Kantarjian","year":"2001"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0140","series-title":"WHO Classification of Tumors of the Haematopoietic and Lymphoid Tissues","first-page":"32","article-title":"Chronic Myeloid Leukemia","author":"Vardiman","year":"2008"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0145","series-title":"Hematopathology","first-page":"698","article-title":"Myeloproliferative neoplasms","author":"Vardiman","year":"2011"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(90)90119-X","article-title":"Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia","volume":"88","author":"Kantarjian","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0155","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood-2012-03-378919","article-title":"How I treat newly diagnosed chronic phase CML","volume":"120","author":"Cortes","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(76)90430-7","article-title":"Blast crisis as an initial or terminal manifestation of chronic myeloid leukemia","volume":"60","author":"Peterson","year":"1976","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jcp.30.3.235","article-title":"Megakaryoblastic transformation of chronic granulocytic leukaemia. An electron microscopy and cytochemical study","volume":"30","author":"Bain","year":"1977","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2141.1979.tb03787.x","article-title":"Ultrastructural localization of peroxidases in \u2018undifferentiated\u2019 blasts during the blast crisis of chronic granulocytic leukemia","volume":"43","author":"Marie","year":"1979","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0175","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/1097-0142(19820301)49:5<921::AID-CNCR2820490516>3.0.CO;2-W","article-title":"Megakaryoblastic transformation of chronic myelogenous leukemia","volume":"49","author":"Williams","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0180","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00320522","article-title":"Megakaryoblastic micromegakaryocytic crisis in chronic myeloid leukemia","volume":"51","author":"Lingg","year":"1985","journal-title":"Blut"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/1097-0142(19870715)60:2<193::AID-CNCR2820600213>3.0.CO;2-U","article-title":"Megakaryoblastic transformation of chronic granulocytic leukemia","volume":"60","author":"Travis","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0190","series-title":"Bone Marrow Pathology","first-page":"204","article-title":"Myeloproliferative disorders","author":"Chronic","year":"2001"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0195","series-title":"Hematopathology","first-page":"656","article-title":"The myelodysplastic syndromes","author":"Hamilton","year":"2011"},{"key":"10.1016\/j.bcmd.2016.05.003_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0609.1998.tb01052.x","article-title":"From megakaryocytes to platelets: platelet morphogenesis takes place in the blood stream","volume":"61","author":"Behnke","year":"1998","journal-title":"Eur. J. Haematol. Suppl."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0205","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1083\/jcb.147.6.1299","article-title":"Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes","volume":"147","author":"Italiano","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.36.1.1","article-title":"Megacaryocytes in the peripheral circulation","volume":"361","author":"Minot","year":"1922","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0215","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcp\/88.5.645","article-title":"Philadelphia chromosome-positive thrombocythemia and megakaryoblast leukemia","volume":"88","author":"Michiels","year":"1987","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2016.05.003_bb0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1600-0609.2002.01638.x","article-title":"Megakaryocytic blast crisis as a first presentation of chronic myeloid leukemia","volume":"69","author":"Pelloso","year":"2002","journal-title":"Eur. J. Haematol."}],"updated-by":[{"DOI":"10.1016\/j.bcmd.2016.11.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000}}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616300523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616300523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T04:20:37Z","timestamp":1718511637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979616300523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":44,"alternative-id":["S1079979616300523"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.05.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High abundance of circulating megakaryocytic cells in chronic myeloid leukemia in Indian patients. Revisiting George Minot to re-interpret megakaryocytic maturation","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}